Joseph Antin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Weisdorf Daniel J; Nelson Gene; Lee Stephanie J; Haagenson Michael; Spellman Stephen; Antin Joseph H; Bolwell Brian; Cahn Jean-Yves; Cervantes Francisco; Copelan Edward; Gale Robert; Gratwohl Alois; Khoury H Jean; McCarthy Philip; Marks David I; Szer Jeff; Woolfrey Ann; Cortes-Franco Jorge; Horowitz Mary M; Arora Mukta;
Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Koreth John; Stevenson Kristen E; Kim Haesook T; Garcia Michael; Ho Vincent T; Armand Philippe; Cutler Corey; Ritz Jerome; Antin Joseph H; Soiffer Robert J; Alyea Edwin P
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Chang Grace; Meadows Mary-Ellen; Orav E John; Antin Joseph H
Mental status changes after hematopoietic stem cell transplantation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Joseph Antin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Weisdorf Daniel J; Nelson Gene; Lee Stephanie J; Haagenson Michael; Spellman Stephen; Antin Joseph H; Bolwell Brian; Cahn Jean-Yves; Cervantes Francisco; Copelan Edward; Gale Robert; Gratwohl Alois; Khoury H Jean; McCarthy Philip; Marks David I; Szer Jeff; Woolfrey Ann; Cortes-Franco Jorge; Horowitz Mary M; Arora Mukta;
Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1475-8.
2009: Koreth John; Stevenson Kristen E; Kim Haesook T; Garcia Michael; Ho Vincent T; Armand Philippe; Cutler Corey; Ritz Jerome; Antin Joseph H; Soiffer Robert J; Alyea Edwin P
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Blood 2009;114(18):3956-9.
2009: Chang Grace; Meadows Mary-Ellen; Orav E John; Antin Joseph H
Mental status changes after hematopoietic stem cell transplantation.
Cancer 2009;115(19):4625-35.
2009: Ho Vincent T; Vanneman Matthew; Kim Haesook; Sasada Tetsuro; Kang Yoon Joong; Pasek Mildred; Cutler Corey; Koreth John; Alyea Edwin; Sarantopoulos Stefanie; Antin Joseph H; Ritz Jerome; Canning Christine; Kutok Jeffery; Mihm Martin C; Dranoff Glenn; Soiffer Robert
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(37):15825-30.
2009: Chen Yi-Bin; Kim Haesook T; McDonough Sean; Odze Robert D; Yao Xiaopan; Lazo-Kallanian Suzan; Spitzer Thomas R; Soiffer Robert; Antin Joseph H; Ritz Jerome
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1066-76.
2009: Ho Vincent T; Aldridge Julie; Kim Haesook T; Cutler Corey; Koreth John; Armand Philippe; Antin Joseph H; Soiffer Robert J; Alyea Edwin P
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):844-50.
2009: Koreth John; Schlenk Richard; Kopecky Kenneth J; Honda Sumihisa; Sierra Jorge; Djulbegovic Benjamin J; Wadleigh Martha; DeAngelo Daniel J; Stone Richard M; Sakamaki Hisashi; Appelbaum Frederick R; Döhner Hartmut; Antin Joseph H; Soiffer Robert J; Cutler Corey
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
JAMA : the journal of the American Medical Association 2009;301(22):2349-61.
2009: Delaney Meghan; Cutler Corey S; Haspel Richard L; Yeap Beow Y; McAfee Steven L; Dey Bimalangshu R; Attar Eyal; Kao Grace; Alyea Edwin P; Koreth John; Ho Vincent T; Saidman Susan; Liney Deborah; Sese Doreen; Soiffer Robert J; Spitzer Thomas R; Antin Joseph H; Ballen Karen K
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
Transfusion 2009;49(5):995-1002.
2009: Arora Mukta; Weisdorf Daniel J; Spellman Stephen R; Haagenson Michael D; Klein John P; Hurley Carolyn K; Selby George B; Antin Joseph H; Kernan Nancy A; Kollman Craig; Nademanee Auayporn; McGlave Philip; Horowitz Mary M; Petersdorf Effie W
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(10):1644-52.
2009: Sarantopoulos Stefanie; Stevenson Kristen E; Kim Haesook T; Cutler Corey S; Bhuiya Nazmim S; Schowalter Michael; Ho Vincent T; Alyea Edwin P; Koreth John; Blazar Bruce R; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
Blood 2009;113(16):3865-74.
2009: Oliansky Denise M; Antin Joseph H; Bennett John M; Deeg H Joachim; Engelhardt Christin; Heptinstall Kathleen V; de Lima Marcos; Gore Steven D; Potts Ronald G; Silverman Lewis R; Jones Roy B; McCarthy Philip L; Hahn Theresa
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):137-72.
2008: Armand Philippe; Gannamaneni Supriya; Kim Haesook T; Cutler Corey S; Ho Vincent T; Koreth John; Alyea Edwin P; LaCasce Ann S; Jacobsen Eric D; Fisher David C; Brown Jennifer R; Canellos George P; Freedman Arnold S; Soiffer Robert J; Antin Joseph H
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5767-74.
2008: Cutler Corey; Stevenson Kristen; Kim Haesook T; Richardson Paul; Ho Vincent T; Linden Erica; Revta Carolyn; Ebert Ruth; Warren Diane; Choi Sung; Koreth John; Armand Philippe; Alyea Edwin; Carter Shelly; Horowitz Mary; Antin Joseph H; Soiffer Robert
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
Blood 2008;112(12):4425-31.
2008: Yanik Gregory A; Ho Vincent T; Levine John E; White Eric S; Braun Thomas; Antin Joseph H; Whitfield Joel; Custer Joseph; Jones Dawn; Ferrara James L M; Cooke Kenneth R
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
Blood 2008;112(8):3073-81.
2008: Armistead Paul M; Mohseni Mehrdad; Gerwin Roslyn; Walsh Emily C; Iravani Masoud; Chahardouli Bahram; Rostami Shahrbano; Zhang Wandi; Neuberg Donna; Rioux John; Ghavamzadeh Ardeshir; Ritz Jerome; Antin Joseph H; Wu Catherine J
Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.
Experimental hematology 2008;36(9):1205-15.
2008: Alyea Edwin P; Li Shuli; Kim Haesook T; Cutler Corey; Ho Vincent; Soiffer Robert J; Antin Joseph H
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):920-6.
2008: Armand Philippe; Kim Haesook T; Ho Vincent T; Cutler Corey S; Koreth John; Antin Joseph H; LaCasce Ann S; Jacobsen Eric D; Fisher David C; Brown Jennifer R; Canellos George P; Freedman Arnold S; Soiffer Robert J; Alyea Edwin P
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):418-25.
2008: Haspel R L; Kao G; Yeap B Y; Cutler C; Soiffer R J; Alyea E P; Ho V T; Koreth J; Dey B R; McAfee S L; Attar E C; Spitzer T; Antin J H; Ballen K K
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.
Bone marrow transplantation 2008;41(6):523-9.
2008: Saito Akiko M; Cutler Corey; Zahrieh David; Soiffer Robert J; Ho Vincent T; Alyea Edwin P; Koreth John; Antin Joseph H; Lee Stephanie J
Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):197-207.
2008: Schlenk Richard F; Pasquini Marcelo C; Pérez Waleska S; Zhang Mei-Jie; Krauter Jürgen; Antin Joseph H; Bashey Asad; Bolwell Brian J; Büchner Thomas; Cahn Jean-Yves; Cairo Mitchell S; Copelan Edward A; Cutler Corey S; Döhner Hartmut; Gale Robert Peter; Ilhan Osman; Lazarus Hillard M; Liesveld Jane L; Litzow Mark R; Marks David I; Maziarz Richard T; McCarthy Philip L; Nimer Stephen D; Sierra Jorge; Tallman Martin S; Weisdorf Daniel J; Horowitz Mary M; Ganser Arnold;
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):187-96.
2008: Treister Nathaniel S; Cook Earl Francis; Antin Joseph; Lee Stephanie J; Soiffer Robert; Woo Sook-Bin
Clinical evaluation of oral chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):110-5.
2008: Armand Philippe; Kim Haesook T; Cutler Corey S; Ho Vincent T; Koreth John; Ritz Jerome; Alyea Edwin P; Antin Joseph H; Soiffer Robert J
A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):28-35.
2008: Cutler Corey; Antin Joseph H
Novel drugs for the prevention and treatment of acute GVHD.
Current pharmaceutical design 2008;14(20):1962-73.
2007: Ferrara James L M; Anasetti Claudio; Stadtmauer Edward; Antin Joseph; Wingard John; Lee Stephanie; Levine John; Schultz Kirk; Appelbaum Frederick; Negrin Robert; Giralt Sergio; Bredeson Christopher; Heslop Helen; Horowitz Mary
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1268-85.
2007: Wu Catherine J; Gladwin Mark; Tisdale John; Hsieh Matthew; Law Terence; Biernacki Melinda; Rogers Shelby; Wang Xunde; Walters Mark; Zahrieh David; Antin Joseph H; Ritz Jerome; Krishnamurti Lakshamanan
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
British journal of haematology 2007;139(3):504-7.
2007: Sarantopoulos Stefanie; Stevenson Kristen E; Kim Haesook T; Bhuiya Nazmim S; Cutler Corey S; Soiffer Robert J; Antin Joseph H; Ritz Jerome
High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6107-14.
2007: Saito A M; Zahrieh D; Cutler C; Ho V T; Antin J H; Soiffer R J; Alyea E P; Lee S J
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy.
Bone marrow transplantation 2007;40(3):209-17.
2007: Seeley W W; Marty F M; Holmes T M; Upchurch K; Soiffer R J; Antin J H; Baden L R; Bromfield E B
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.
Neurology 2007;69(2):156-65.
2007: Ballen Karen K; Shpall Elizabeth J; Avigan David; Yeap Beow Y; Fisher David C; McDermott Kathleen; Dey Bimalangshu R; Attar Eyal; McAfee Steven; Konopleva Marina; Antin Joseph H; Spitzer Thomas R
Phase I trial of parathyroid hormone to facilitate stem cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):838-43.
2007: Marty Francisco M; Bryar Julie; Browne Sarah K; Schwarzberg Talya; Ho Vincent T; Bassett Ingrid V; Koreth John; Alyea Edwin P; Soiffer Robert J; Cutler Corey S; Antin Joseph H; Baden Lindsey R
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis.
Blood 2007;110(2):490-500.
2007: Armand Philippe; Kim Haesook T; DeAngelo Daniel J; Ho Vincent T; Cutler Corey S; Stone Richard M; Ritz Jerome; Alyea Edwin P; Antin Joseph H; Soiffer Robert J
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):655-64.
2007: Armand Philippe; Antin Joseph H
Allogeneic stem cell transplantation for aplastic anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):505-16.
2007: Armand Philippe; Kim Haesook T; Cutler Corey S; Ho Vincent T; Koreth John; Alyea Edwin P; Soiffer Robert J; Antin Joseph H
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.
Blood 2007;109(10):4586-8.
2007: Cutler Corey; Li Shuli; Ho Vincent T; Koreth John; Alyea Edwin; Soiffer Robert J; Antin Joseph H
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.
Blood 2007;109(7):3108-14.
2007: Ballen Karen K; Spitzer Thomas R; Yeap Beow Y; McAfee Steven; Dey Bimalangshu R; Attar Eyal; Haspel Richard; Kao Grace; Liney Deborah; Alyea Edwin; Lee Stephanie; Cutler Corey; Ho Vincent; Soiffer Robert; Antin Joseph H
Double unrelated reduced-intensity umbilical cord blood transplantation in adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1):82-9.
2007: Antin Joseph H
Reduced-Intensity Stem Cell Transplantation: "...whereof a little More than a little is by much too much." King Henry IV, part 1, I, 2.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():47-54.
2006: Brown Jennifer R; Kim Haesook T; Li Shuli; Stephans Katherine; Fisher David C; Cutler Corey; Ho Vincent; Lee Stephanie J; Milford Edgar L; Ritz Jerome; Antin Joseph H; Soiffer Robert J; Gribben John G; Alyea Edwin P
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1056-64.
2006: Alyea Edwin P; Kim Haesook T; Ho Vincent; Cutler Corey; DeAngelo Daniel J; Stone Richard; Ritz Jerome; Antin Joseph H; Soiffer Robert J
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1047-55.
2006: Humphreys Benjamin D; Vanguri Vijay K; Henderson Joel; Antin Joseph H
Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient.
Nature clinical practice. Nephrology 2006;2(9):535-9; quiz 540.
2006: Lee S J; Kim H T; Ho V T; Cutler C; Alyea E P; Soiffer R J; Antin J H
Quality of life associated with acute and chronic graft-versus-host disease.
Bone marrow transplantation 2006;38(4):305-10.
2006: Cutler Corey; Miklos David; Kim Haesook T; Treister Nathaniel; Woo Sook-Bin; Bienfang Don; Klickstein Lloyd B; Levin Jesse; Miller Katherine; Reynolds Carol; Macdonell Rebecca; Pasek Mildred; Lee Stephanie J; Ho Vincent; Soiffer Robert; Antin Joseph H; Ritz Jerome; Alyea Edwin
Rituximab for steroid-refractory chronic graft-versus-host disease.
Blood 2006;108(2):756-62.
2006: Marty Francisco M; Lowry Colleen M; Cutler Corey S; Campbell Bonnie J; Fiumara Karen; Baden Lindsey R; Antin Joseph H
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):552-9.
2006: Ho V T; Kim H T; Liney D; Milford E; Gribben J; Cutler C; Lee S J; Antin J H; Soiffer R J; Alyea E P
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.
Bone marrow transplantation 2006;37(9):845-50.
2006: Cutler Corey; Antin Joseph H
Chronic graft-versus-host disease.
Current opinion in oncology 2006;18(2):126-31.
2006: Deeg H Joachim; Antin Joseph H
The clinical spectrum of acute graft-versus-host disease.
Seminars in hematology 2006;43(1):24-31.
2006: Porter David L; Antin Joseph H
Donor leukocyte infusions in myeloid malignancies: new strategies.
Best practice & research. Clinical haematology 2006;19(4):737-55.
2005: Antin Joseph H
Approaches to graft-vs-host disease.
Pediatric transplantation 2005;9 Suppl 7():71-5.
2005: Cutler Corey; Antin Joseph H
An overview of hematopoietic stem cell transplantation.
Clinics in chest medicine 2005;26(4):517-27, v.
2005: Wu Catherine J; Krishnamurti Lakshamanan; Kutok Jeffery L; Biernacki Melinda; Rogers Shelby; Zhang Wandi; Antin Joseph H; Ritz Jerome
Evidence for ineffective erythropoiesis in severe sickle cell disease.
Blood 2005;106(10):3639-45.
2005: Zorn Emmanuel; Kim Haesook T; Lee Stephanie J; Floyd Blair H; Litsa Despina; Arumugarajah Sankari; Bellucci Roberto; Alyea Edwin P; Antin Joseph H; Soiffer Robert J; Ritz Jerome
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Blood 2005;106(8):2903-11.
2005: Cahn Jean-Yves; Klein John P; Lee Stephanie J; Milpied Noël; Blaise Didier; Antin Joseph H; Leblond Véronique; Ifrah Norbert; Jouet Jean-Pierre; Loberiza Fausto; Ringden Olle; Barrett A John; Horowitz Mary M; Socié Gérard;
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study.
Blood 2005;106(4):1495-500.
2005: Cutler Corey; Henry N Lynn; Magee Colm; Li Shuli; Kim Haesook T; Alyea Edwin; Ho Vincent; Lee Stephanie J; Soiffer Robert; Antin Joseph H
Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):551-7.
2005: Antin Joseph H
Donor leukocyte infusions and graft-versus-malignancy.
Journal of clinical apheresis 2005;20(2):113-6.
2005: Cutler Corey; Li Shuli; Kim Haesook T; Laglenne Patricia; Szeto Kwok Chuen; Hoffmeister Laura; Harrison M Joel; Ho Vincent; Alyea Edwin; Lee Stephanie J; Soiffer Robert; Sonis Stephen; Antin Joseph H
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):383-8.
2005: Miklos David B; Kim Haesook T; Miller Katherine H; Guo Luxuan; Zorn Emmanuel; Lee Stephanie J; Hochberg Ephraim P; Wu Catherine J; Alyea Edwin P; Cutler Corey; Ho Vincent; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.
Blood 2005;105(7):2973-8.
2005: Antin Joseph H; Guinan Eva C; Avigan David; Soiffer Robert J; Joyce Robin M; Martin Victoria J; Molrine Deborah C
Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):213-22.
2005: Peters Brock A; Diaz Luis A; Polyak Kornelia; Meszler Leslie; Romans Kathy; Guinan Eva C; Antin Joseph H; Myerson David; Hamilton Stanley R; Vogelstein Bert; Kinzler Kenneth W; Lengauer Christoph
Contribution of bone marrow-derived endothelial cells to human tumor vasculature.
Nature medicine 2005;11(3):261-2.
2005: Antin Joseph H
Immune reconstitution: the major barrier to successful stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2 Suppl 2):43-5.
2005: Oh Hakumei; Loberiza Fausto R; Zhang Mei-jie; Ringdén Olle; Akiyama Hideki; Asai Takayoshi; Miyawaki Shuichi; Okamoto Shinichiro; Horowitz Mary M; Antin Joseph H; Bashey Asad; Bird Jennifer M; Carabasi Matthew H; Fay Joseph W; Gale Robert Peter; Giller Roger H; Goldman John M; Hale Gregory A; Harris Richard E; Henslee-Downey Jean; Kolb Hans-Jochem; Litzow Mark R; McCarthy Philip L; Neudorf Steven M; Serna Derek S; Socié Gerard; Tiberghien Pierre; Barrett A John
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood 2005;105(4):1408-16.
2005: Alyea Edwin P; Kim Haesook T; Ho Vincent; Cutler Corey; Gribben John; DeAngelo Daniel J; Lee Stephanie J; Windawi Sarah; Ritz Jerome; Stone Richard M; Antin Joseph H; Soiffer Robert J
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.
Blood 2005;105(4):1810-4.
2005: Chang Grace; Orav E John; McNamara Tay K; Tong Mei-Yee; Antin Joseph H
Psychosocial function after hematopoietic stem cell transplantation.
Psychosomatics 2005;46(1):34-40.
2005: Lee S J; Loberiza F R; Antin J H; Kirkpatrick T; Prokop L; Alyea E P; Cutler C; Ho V T; Richardson P G; Schlossman R L; Fisher D C; Logan B; Soiffer R J
Routine screening for psychosocial distress following hematopoietic stem cell transplantation.
Bone marrow transplantation 2005;35(1):77-83.
2005: Hodi F Stephen; Granter Scott; Antin Joseph
Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report.
Cancer immunity : a journal of the Academy of Cancer Immunology 2005;5():7.
2004: Ho V T; Kim H T; Li S; Hochberg E P; Cutler C; Lee S J; Fisher D C; Milford E; Kao G; Daley H; Levin J; Ng A; Mauch P; Alyea E P; Antin J H; Soiffer R J
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
Bone marrow transplantation 2004;34(11):987-94.
2004: Raje Noopur; Kumar Shaji; Hideshima Teru; Ishitsuka Kenji; Chauhan Dharminder; Mitsiades Constantine; Podar Klaus; Le Gouill Steven; Richardson Paul; Munshi Nikhil C; Stirling David I; Antin Joseph H; Anderson Kenneth C
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma.
Blood 2004;104(13):4188-93.
2004: Antin Joseph H; Chen Allen R; Couriel Daniel R; Ho Vincent T; Nash Richard A; Weisdorf Daniel
Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):655-68.
2004: Cutler Corey; Antin Joseph H
Mammalian target of rapamycin inhibition as therapy for hematologic malignancies.
Cancer 2004;101(6):1478; author reply 1478.
2004: Chang Grace; Orav E John; Tong Mei-Yee; Antin Joseph H
Predictors of 1-year survival assessed at the time of bone marrow transplantation.
Psychosomatics 2004;45(5):378-85.
2004: Cutler C; Antin J H
Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.
Bone marrow transplantation 2004;34(6):471-6.
2004: Lee Stephanie J; Zahrieh David; Agura Edward; MacMillan Margaret L; Maziarz Richard T; McCarthy Philip L; Ho Vincent T; Cutler Corey; Alyea Edwin P; Antin Joseph H; Soiffer Robert J
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.
Blood 2004;104(5):1559-64.
2004: Chang Grace; Orav E John; McNamara Tay; Tong Mei-Yee; Antin Joseph H
Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome.
Cancer 2004;101(4):782-9.
2004: DeAngelo Daniel J; Hochberg Ephraim P; Alyea Edwin P; Longtine Janina; Lee Stephanie; Galinsky Ilene; Parekkedon Ben; Ritz Jerome; Antin Joseph H; Stone Richard M; Soiffer Robert J
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5065-71.
2004: Ho Vincent T; Zahrieh David; Hochberg Ephraim; Micale Eileen; Levin Jesse; Reynolds Carol; Steckel Steve; Cutler Corey; Fisher David C; Lee Stephanie J; Alyea Edwin P; Ritz Jerome; Soiffer Robert J; Antin Joseph H
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(4):1224-6.
2004: Cutler Corey S; Lee Stephanie J; Greenberg Peter; Deeg H Joachim; Pérez Waleska S; Anasetti Claudio; Bolwell Brian J; Cairo Mitchell S; Gale Robert Peter; Klein John P; Lazarus Hillard M; Liesveld Jane L; McCarthy Philip L; Milone Gustavo A; Rizzo J Douglas; Schultz Kirk R; Trigg Michael E; Keating Armand; Weisdorf Daniel J; Antin Joseph H; Horowitz Mary M
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
Blood 2004;104(2):579-85.
2004: Cutler Corey; Kim Haesook T; Hochberg Ephraim; Ho Vincent; Alyea Edwin; Lee Stephanie J; Fisher David C; Miklos David; Levin Jesse; Sonis Stephen; Soiffer Robert J; Antin Joseph H
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):328-36.
2004: Zorn Emmanuel; Miklos David B; Floyd Blair H; Mattes-Ritz Alex; Guo Luxuan; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation.
The Journal of experimental medicine 2004;199(8):1133-42.
2004: Zubair Abba C; Zahrieh David; Daley Heather; Schott Darlys; Gribben John G; Alyea Edwin P; Schlossman Robert; Freedman Arnold; Antin Joseph H; Soiffer Robert J; Neuberg Donna; Ritz Jerome
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy.
Transfusion 2004;44(2):253-61.
2004: Miklos David B; Kim Haesook T; Zorn Emmanuel; Hochberg Ephraim P; Guo Luxuan; Mattes-Ritz Alex; Viatte Sebastien; Soiffer Robert J; Antin Joseph H; Ritz Jerome
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.
Blood 2004;103(1):353-9.
2004: Milinkovic Mirjana; Antin Joseph H; Hergrueter Charles A; Underhill Charles B; Sackstein Robert
CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD.
Blood 2004;103(2):740-2.
2003: Spiryda Lisa B; Laufer Marc R; Soiffer Robert J; Antin Joseph A
Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(12):760-5.
2003: Antin Joseph H
Stem cell transplantation-harnessing of graft-versus-malignancy.
Current opinion in hematology 2003;10(6):440-4.
2003: Marty Francisco M; Lee Stephanie J; Fahey Michelle M; Alyea Edwin P; Soiffer Robert J; Antin Joseph H; Baden Lindsey R
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.
Blood 2003;102(8):2768-76.
2003: Wadleigh Martha; Richardson Paul G; Zahrieh David; Lee Stephanie J; Cutler Corey; Ho Vincent; Alyea Edwin P; Antin Joseph H; Stone Richard M; Soiffer Robert J; DeAngelo Daniel J
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation.
Blood 2003;102(5):1578-82.
2003: Antin Joseph H; Kim Haesook T; Cutler Corey; Ho Vincent T; Lee Stephanie J; Miklos David B; Hochberg Ephraim P; Wu Catherine J; Alyea Edwin P; Soiffer Robert J
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
Blood 2003;102(5):1601-5.
2003: Antin Joseph H
A 41-year-old woman with chronic myelogenous leukemia.
JAMA : the journal of the American Medical Association 2003;290(8):1083-90.
2003: Akpek Gorgun; Lee Stephanie J; Flowers Mary E; Pavletic Steven Z; Arora Mukta; Lee Shing; Piantadosi Steven; Guthrie Katherine A; Lynch James C; Takatu Alessandra; Horowitz Mary M; Antin Joseph H; Weisdorf Daniel J; Martin Paul J; Vogelsang Georgia B
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.
Blood 2003;102(3):802-9.
2003: Lee Stephanie J; Loberiza Fausto R; Rizzo J Douglas; Soiffer Robert J; Antin Joseph H; Weeks Jane C
Optimistic expectations and survival after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(6):389-96.
2003: Molrine Deborah C; Antin Joseph H; Guinan Eva C; Soiffer Robert J; MacDonald Kristin; Malley Richard; Malinoski Frank; Trocciola Susan; Wilson Marjorie; Ambrosino Donna M
Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation.
Blood 2003;101(3):831-6.
2003: Chang Grace; McGarigle Carol; Koby Danielle; Antin Joseph H
Symptoms of pain and depression in related marrow donors: changes after transplant.
Psychosomatics 2003;44(1):59-64.
2003: Hochberg Ephraim P; Miklos David B; Neuberg Donna; Eichner Daniel A; McLaughlin Stephen F; Mattes-Ritz Alex; Alyea Edwin P; Antin Joseph H; Soiffer Robert J; Ritz Jerome
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.
Blood 2003;101(1):363-9.
2002: DiNubile Mark J; Stossel Thomas P; Ljunghusen Olof C; Ferrara James L M; Antin Joseph H
Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation.
Blood 2002;100(13):4367-71.
2002: Richardson Paul G; Murakami Carol; Jin Zhezhen; Warren Diane; Momtaz Parisa; Hoppensteadt Deborah; Elias Anthony D; Antin Joseph H; Soiffer Robert; Spitzer Thomas; Avigan David; Bearman Scott I; Martin Paul L; Kurtzberg Joanne; Vredenburgh James; Chen Allen R; Arai Sally; Vogelsang Georgia; McDonald George B; Guinan Eva C
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.
Blood 2002;100(13):4337-43.
2002: Antin Joseph H; Weisdorf Daniel; Neuberg Donna; Nicklow Roberta; Clouthier Shawn; Lee Stephanie J; Alyea Edwin; McGarigle Carol; Blazar Bruce R; Sonis Stephen; Soiffer Robert J; Ferrara James L M
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.
Blood 2002;100(10):3479-82.
2002: Lee Stephanie J; Zahrieh David; Alyea Edwin P; Weller Edie; Ho Vincent T; Antin Joseph H; Soiffer Robert J
Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs.
Blood 2002;100(8):2697-702.
2002: Lin Thomas S; Zahrieh David; Weller Edie; Alyea Edwin P; Antin Joseph H; Soiffer Robert J
Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Transplantation 2002;74(1):49-54.
2002: Antin Joseph H
Clinical practice. Long-term care after hematopoietic-cell transplantation in adults.
The New England journal of medicine 2002;347(1):36-42.
2002: Lee Stephanie J; Klein John P; Barrett A John; Ringden Olle; Antin Joseph H; Cahn Jean-Yves; Carabasi Matthew H; Gale Robert Peter; Giralt Sergio; Hale Gregory A; Ilhan Osman; McCarthy Philip L; Socie Gerard; Verdonck Leo F; Weisdorf Daniel J; Horowitz Mary M
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.
Blood 2002;100(2):406-14.
2002: Loberiza Fausto R; Rizzo J Douglas; Bredeson Christopher N; Antin Joseph H; Horowitz Mary M; Weeks Jane C; Lee Stephanie J
Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2118-26.
2002: Antin J H; Lee S J; Neuberg D; Alyea E; Soiffer R J; Sonis S; Ferrara J L M
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.
Bone marrow transplantation 2002;29(5):373-7.
2002: Weisdorf Daniel J; Anasetti Claudio; Antin Joseph H; Kernan Nancy A; Kollman Craig; Snyder David; Petersdorf Effie; Nelson Gene; McGlave Philip
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
Blood 2002;99(6):1971-7.
2002: Soiffer Robert J; Alyea Edwin P; Hochberg Ephraim; Wu Catherine; Canning Christine; Parikh Bijal; Zahrieh David; Webb Iain; Antin Joseph; Ritz Jerome
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(11):625-32.
2002: Alyea Edwin P; Weller Edie; Fisher David C; Freedman Arnold S; Gribben John G; Lee Stephanie; Schlossman Robert L; Stone Richard M; Friedberg Jonathan; DeAngelo Daniel; Liney Deborah; Windawi Sarah; Ng Andrea; Mauch Peter; Antin Joseph H; Soiffer Robert J
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(11):601-7.
2002: Lee Stephanie k; Cook E Francis; Soiffer Robert; Antin Joseph H
Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(8):444-52.
2002: Martin Paul J; Antin Joseph H; Weisdorf Daniel J; Paton Virginia; Horowitz Mary M
Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(6):295-302.
2002: Lee Stephanie J; Vogelsang Georgia; Gilman Andrew; Weisdorf Daniel J; Pavletic Steven; Antin Joseph H; Horowitz Mary M; Akpek Gorgun; Flowers Mary E; Couriel Daniel; Martin Paul J
A survey of diagnosis, management, and grading of chronic GVHD.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(1):32-9.
2001: Lee S J; Klein J P; Anasetti C; Antin J H; Loberiza F R; Bolwell B J; LeMaistre C F; Litzow M R; Marks D; Waller E K; Matlack M; Giralt S; Horowitz M M
The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.
Blood 2001;98(12):3205-11.
2001: Kollman C; Howe C W; Anasetti C; Antin J H; Davies S M; Filipovich A H; Hegland J; Kamani N; Kernan N A; King R; Ratanatharathorn V; Weisdorf D; Confer D L
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.
Blood 2001;98(7):2043-51.
2001: Cutler C; Giri S; Jeyapalan S; Paniagua D; Viswanathan A; Antin J H
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(16):3685-91.
2001: Winston D J; Antin J H; Wolff S N; Bierer B E; Small T; Miller K B; Linker C; Kaizer H; Lazarus H M; Petersen F B; Cowan M J; Ho W G; Wingard J R; Schiller G J; Territo M C; Jiao J; Petrarca M A; Tonetta S A
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Bone marrow transplantation 2001;28(2):187-96.
2001: Antin J H
Acute graft-versus-host disease: inflammation run amok?
The Journal of clinical investigation 2001;107(12):1497-8.
2001: Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Leukemia & lymphoma 2001;40(5-6):499-509.
2001: Lee S J; Fairclough D; Antin J H; Weeks J C
Discrepancies between patient and physician estimates for the success of stem cell transplantation.
JAMA : the journal of the American Medical Association 2001;285(8):1034-8.
2001: Soiffer R J; Weller E; Alyea E P; Mauch P; Webb I L; Fisher D C; Freedman A S; Schlossman R L; Gribben J; Lee S; Anderson K C; Marcus K; Stone R M; Antin J H; Ritz J
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1152-9.
2001: Lee S J; Fairclough D; Parsons S K; Soiffer R J; Fisher D C; Schlossman R L; Antin J H; Weeks J C
Recovery after stem-cell transplantation for hematologic diseases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):242-52.
2001: Antin J H; Childs R; Filipovich A H; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(9):473-85.
2001: Porter D L; Luger S M; Duffy K M; Stadtmauer E A; Laport G; Schuster S J; Orloff G; Tsai D; McDaid K; Kathakali A; Leonard D G; Antin J H
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):230-8.
2001: Ho V T; Weller E; Lee S J; Alyea E P; Antin J H; Soiffer R J
Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):223-9.
2001: Cutler C; Antin J H
Peripheral blood stem cells for allogeneic transplantation: a review.
Stem cells (Dayton, Ohio) 2001;19(2):108-17.
2000: Davies S M; Kollman C; Anasetti C; Antin J H; Gajewski J; Casper J T; Nademanee A; Noreen H; King R; Confer D; Kernan N A
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.
Blood 2000;96(13):4096-102.
2000: Nash R A; Antin J H; Karanes C; Fay J W; Avalos B R; Yeager A M; Przepiorka D; Davies S; Petersen F B; Bartels P; Buell D; Fitzsimmons W; Anasetti C; Storb R; Ratanatharathorn V
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Blood 2000;96(6):2062-8.
2000: McGlave P B; Shu X O; Wen W; Anasetti C; Nademanee A; Champlin R; Antin J H; Kernan N A; King R; Weisdorf D J
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program.
Blood 2000;95(7):2219-25.
2000: Porter D L; Collins R H; Hardy C; Kernan N A; Drobyski W R; Giralt S; Flowers M E; Casper J; Leahey A; Parker P; Mick R; Bate-Boyle B; King R; Antin J H
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions.
Blood 2000;95(4):1214-21.
2000: Lee S J; Klar N; Weeks J C; Antin J H
Predicting costs of stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):64-71.
2000: Vasconcelles M J; Bernardo M V; King C; Weller E A; Antin J H
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):35-43.
1999: Benjamin R J; Antin J H
ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity.
Transfusion 1999;39(11-12):1273-4.
1999: Porter D L; Connors J M; Van Deerlin V M; Duffy K M; McGarigle C; Saidman S L; Leonard D G; Antin J H
Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1234.
1999: Sehn L H; Alyea E P; Weller E; Canning C; Lee S; Ritz J; Antin J H; Soiffer R J
Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):561-8.
1999: Benjamin R J; McGurk S; Ralston M S; Churchill W H; Antin J H
ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.
Transfusion 1999;39(2):179-87.
1999: Porter D L; Collins R H; Shpilberg O; Drobyski W R; Connors J M; Sproles A; Antin J H
Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(4):253-61.
1999: Porter D L; Antin J H
The graft-versus-leukemia effects of allogeneic cell therapy.
Annual review of medicine 1999;50():369-86.
1998: Przepiorka D; Phillips G L; Ratanatharathorn V; Cottler-Fox M; Sehn L H; Antin J H; LeBherz D; Awwad M; Hope J; McClain J B
A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.
Blood 1998;92(11):4066-71.
1998: Lee S J; Anasetti C; Kuntz K M; Patten J; Antin J H; Weeks J C
The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.
Blood 1998;92(11):4047-52.
1998: Vance E; George S; Guinan E C; Wheeler C; Antin J H; Ambrosino D M; Molrine D C
Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
Bone marrow transplantation 1998;22(8):735-41.
1998: Ratanatharathorn V; Nash R A; Przepiorka D; Devine S M; Klein J L; Weisdorf D; Fay J W; Nademanee A; Antin J H; Christiansen N P; van der Jagt R; Herzig R H; Litzow M R; Wolff S N; Longo W L; Petersen F B; Karanes C; Avalos B; Storb R; Buell D N; Maher R M; Fitzsimmons W E; Wingard J R
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Blood 1998;92(7):2303-14.
1998: Lee S J; Anasetti C; Horowitz M M; Antin J H
Initial therapy for chronic myelogenous leukemia: playing the odds.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2897-903.
1998: Kraus M D; Shahsafaei A; Antin J; Odze R D
Relationship of Bcl-2 expression with apoptosis and proliferation in colonic graft versus host disease.
Human pathology 1998;29(8):869-75.
1998: Richardson P G; Elias A D; Krishnan A; Wheeler C; Nath R; Hoppensteadt D; Kinchla N M; Neuberg D; Waller E K; Antin J H; Soiffer R; Vredenburgh J; Lill M; Woolfrey A E; Bearman S I; Iacobelli M; Fareed J; Guinan E C
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
Blood 1998;92(3):737-44.
1998: Chang G; McGarigle C; Spitzer T R; McAfee S L; Harris F; Piercy K; Goetz M N; Antin J H
A comparison of related and unrelated marrow donors.
Psychosomatic medicine 1998;60(2):163-7.
1998: Porter D L; Antin J H
Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemia.
Hematology/oncology clinics of North America 1998;12(1):123-50.
1998: Kraus M D; Feran-Doza M; Garcia-Moliner M L; Antin J; Odze R D
Cytomegalovirus infection in the colon of bone marrow transplantation patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(1):29-36.
1998: Boswell G W; Bekersky I; Fay J; Wingard J; Antin J; Weisdorf D; Maher R; Fitzsimmons W; Nash R
Tacrolimus pharmacokinetics in BMT patients.
Bone marrow transplantation 1998;21(1):23-8.
1998: Sehn L H; Antin J H; Shulman L N; Mauch P; Elias A; Kadin M E; Wheeler C
Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.
Blood 1998;91(2):717-23.
1998: Ziegler T R; Bye R L; Persinger R L; Young L S; Antin J H; Wilmore D W
Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study.
The American journal of the medical sciences 1998;315(1):4-10.
1998: Benjamin R J; Connors J M; McGurk S; Churchill W H; Antin J H
Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):151-6.
1997: Lee S J; Kuntz K M; Horowitz M M; McGlave P B; Goldman J M; Sobocinski K A; Hegland J; Kollman C; Parsons S K; Weinstein M C; Weeks J C; Antin J H
Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.
Annals of internal medicine 1997;127(12):1080-8.
1997: Wen P Y; Alyea E P; Simon D; Herbst R S; Soiffer R J; Antin J H
Guillain-Barré syndrome following allogeneic bone marrow transplantation.
Neurology 1997;49(6):1711-4.
1997: Ballen K K; Gilliland D G; Guinan E C; Hsieh C C; Parsons S K; Rimm I J; Ferrara J L; Bierer B E; Weinstein H J; Antin J H
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.
Bone marrow transplantation 1997;20(9):737-43.
1997: Andrykowski M A; Carpenter J S; Greiner C B; Altmaier E M; Burish T G; Antin J H; Gingrich R; Cordova M J; Henslee-Downey P J
Energy level and sleep quality following bone marrow transplantation.
Bone marrow transplantation 1997;20(8):669-79.
1997: Chan C Y; Molrine D C; Antin J H; Wheeler C; Guinan E C; Weinstein H J; Phillips N R; McGarigle C; Harvey S; Schnipper C; Ambrosino D M
Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).
Bone marrow transplantation 1997;20(1):33-8.
1997: Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder J P; Mazanet R; Ferrara J; Rimm I J; Guinan E; Bierer B; Gilliland G; Churchill W H; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):98-106.
1997: Fountain D; Ralston M; Higgins N; Gorlin J B; Uhl L; Wheeler C; Antin J H; Churchill W H; Benjamin R J
Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components.
Transfusion 1997;37(6):585-91.
1997: Chang G; Antin J H; Orav E J; Randall U; McGarigle C; Behr H M
Substance abuse and bone marrow transplant.
The American journal of drug and alcohol abuse 1997;23(2):301-8.
1997: Lee S J; Wegner S A; McGarigle C J; Bierer B E; Antin J H
Treatment of chronic graft-versus-host disease with clofazimine.
Blood 1997;89(7):2298-302.
1997: Collins R H; Shpilberg O; Drobyski W R; Porter D L; Giralt S; Champlin R; Goodman S A; Wolff S N; Hu W; Verfaillie C; List A; Dalton W; Ognoskie N; Chetrit A; Antin J H; Nemunaitis J
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):433-44.
1997: Lee S J; Churchill W H; Konugres A; Gilliland D G; Antin J H
Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulin.
Bone marrow transplantation 1997;19(2):173-4.
1997: Benjamin R J; Linsley L; Fountain D; Churchill W H; Sieff C; Cannon M E; Uhl L; Gaynes L; Antin J H; Wheeler C
Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield.
Transfusion 1997;37(1):79-85.
1997: Porter D L; Antin J H
Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions.
Cancer treatment and research 1997;77():57-85.
1996: Nichols W C; Antin J H; Lunetta K L; Terry V H; Hertel C E; Wheatley M A; Arnold N D; Siemieniak D R; Boehnke M; Ginsburg D
Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease.
Blood 1996;88(12):4429-34.
1996: Porter D L; Roth M S; Lee S J; McGarigle C; Ferrara J L; Antin J H
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;18(5):975-80.
1996: Molrine D C; Guinan E C; Antin J H; Wheeler C; Parsons S K; Weinstein H J; McGarigle C; Blanding P; Phillips N R; Ciamarra A; George S; Ambrosino D M
Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation.
Bone marrow transplantation 1996;17(6):1149-55.
1996: Woo S B; Allen C M; Orden A; Porter D; Antin J H
Non-gingival soft tissue growths after allogeneic marrow transplantation.
Bone marrow transplantation 1996;17(6):1127-32.
1996: Molrine D C; Guinan E C; Antin J H; Parsons S K; Weinstein H J; Wheeler C; McGarigle C; Blanding P; Phillips N R; Kinsella K; Deans K; Ciamarra A; Goorin A; George S; Ambrosino D M
Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation.
Blood 1996;87(7):3012-8.
1996: Fay J W; Wingard J R; Antin J H; Collins R H; Piñeiro L A; Blazar B R; Saral R; Bierer B E; Przepiorka D; Fitzsimmons W E; Maher R M; Weisdorf D J
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
Blood 1996;87(8):3514-9.
1995: Schwartz R B; Bravo S M; Klufas R A; Hsu L; Barnes P D; Robson C D; Antin J H
Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.
AJR. American journal of roentgenology 1995;165(3):627-31.
1995: Andrykowski M A; Greiner C B; Altmaier E M; Burish T G; Antin J H; Gingrich R; McGarigle C; Henslee-Downey P J
Quality of life following bone marrow transplantation: findings from a multicentre study.
British journal of cancer 1995;71(6):1322-9.
1995: Porter D L; Antin J H
Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation.
Leukemia & lymphoma 1995;17(3-4):191-7.
1995: Andrykowski M A; Brady M J; Greiner C B; Altmaier E M; Burish T G; Antin J H; Gingrich R; McGarigle C; Henslee-Downey P J
'Returning to normal' following bone marrow transplantation: outcomes, expectations and informed consent.
Bone marrow transplantation 1995;15(4):573-81.
1995: Mitus A J; Miller K B; Schenkein D P; Ryan H F; Parsons S K; Wheeler C; Antin J H
Improved survival for patients with acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):560-9.
1994: Pai S Y; Fruman D A; Leong T; Neuberg D; Rosano T G; McGarigle C; Antin J H; Bierer B E
Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A.
Blood 1994;84(11):3974-9.
1994: Porter D L; Orloff G J; Antin J H
Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.
Transplantation science 1994;4(1):12-4; discussion 14-6.
1994: Antin J H; Weinstein H J; Guinan E C; McCarthy P; Bierer B E; Gilliland D G; Parsons S K; Ballen K K; Rimm I J; Falzarano G
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.
Blood 1994;84(4):1342-8.
1994: Mitus A J; Antin J H; Rutherford C J; McGarigle C J; Goldberg M A
Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.
Blood 1994;83(7):1952-7.
1994: Guinan E C; Molrine D C; Antin J H; Lee M C; Weinstein H J; Sallan S E; Parsons S K; Wheeler C; Gross W; McGarigle C
Polysaccharide conjugate vaccine responses in bone marrow transplant patients.
Transplantation 1994;57(5):677-84.
1994: Porter D L; Roth M S; McGarigle C; Ferrara J L; Antin J H
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
The New England journal of medicine 1994;330(2):100-6.
1994: Antin J H
Cytokines and graft-V-host disease.
Progress in clinical and biological research 1994;390():193-202.
1993: Antin J H
Graft-versus-leukemia: no longer an epiphenomenon.
Blood 1993;82(8):2273-7.
1993: Shulman L N; Frisard B; Antin J H; Wheeler C; Pinkus G; Magauran N; Mauch P; Nobles E; Mashal R; Canellos G
Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):937-42.
1993: Ballen K K; Antin J H
Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
Hematology/oncology clinics of North America 1993;7(2):477-93.
1993: Stroncek D F; Holland P V; Bartch G; Bixby T; Simmons R G; Antin J H; Anderson K C; Ash R C; Bolwell B J; Hansen J A
Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program.
Blood 1993;81(7):1940-6.
1993: Araten D J; Lawton T; Ferrara J; Antin J H; Milford E; Carpenter C B; Maziarz R T
In vitro alloreactivity against host antigens in an adult HLA-mismatched bone marrow transplant recipient despite in vivo host tolerance.
Transplantation 1993;55(1):76-82.
1992: Antin J H; Ferrara J L
Cytokine dysregulation and acute graft-versus-host disease.
Blood 1992;80(12):2964-8.
1992: Ballen K K; Donadio D; Bouloux C; McCarthy P; Weinstein H; Antin J H
Herpes simplex virus and neutropenia following bone marrow transplantation.
Transplantation 1992;54(3):553-5.
1992: Aird W; Labopin M; Gorin N C; Antin J H
Long-term cryopreservation of human stem cells.
Bone marrow transplantation 1992;9(6):487-90.
1992: Ziegler T R; Young L S; Benfell K; Scheltinga M; Hortos K; Bye R; Morrow F D; Jacobs D O; Smith R J; Antin J H
Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.
Annals of internal medicine 1992;116(10):821-8.
1992: Wen P Y; Blanchard K L; Block C C; Loeffler J S; Davis D G; Lacroix L A; Antin J H
Development of Lhermitte's sign after bone marrow transplantation.
Cancer 1992;69(9):2262-6.
1992: Moore F D; Jack R M; Antin J H
Peripheral blood neutrophils in chronically neutropenic patients respond to granulocyte-macrophage colony-stimulating factor with a specific increase in CR1 expression and CR1 transcription.
Blood 1992;79(7):1667-71.
1992: Roth M S; Antin J H; Ash R; Terry V H; Gotlieb M; Silver S M; Ginsburg D
Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
Blood 1992;79(1):276-82.
1991: Schneider L C; Antin J H; Weinstein H; Abrams J S; Pearce M K; Geha R S; Vercelli D
Lymphokine profile in bone marrow transplant recipients.
Blood 1991;78(11):3076-80.
1991: Scheltinga M R; Young L S; Benfell K; Bye R L; Ziegler T R; Santos A A; Antin J H; Schloerb P R; Wilmore D W
Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress.
Annals of surgery 1991;214(4):385-93; discussion 393-5.
1991: Antin J H; Bierer B E; Smith B R; Ferrara J; Guinan E C; Sieff C; Golan D E; Macklis R M; Tarbell N J; Lynch E
Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.
Blood 1991;78(8):2139-49.
1991: Braverman A C; Antin J H; Plappert M T; Cook E F; Lee R T
Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1215-23.
1991: Goldberg M A; Gaut C C; Schapira L; Antin J H; Ransil B J; Antman K H; Eder J P; McGarigle C J; Bunn H F
Erythropoietin gene regulation: from the laboratory to the bedside.
Contributions to nephrology 1991;88():35-45; discussion 46-7.
1990: Schapira L; Antin J H; Ransil B J; Antman K H; Eder J P; McGarigle C J; Goldberg M A
Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy.
Blood 1990;76(11):2354-9.
1990: Longmore G; Guinan E C; Weinstein H J; Gelber R D; Rappeport J M; Antin J H
Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1707-14.
1990: Ayash L J; Hunt M; Antman K; Nadler L; Wheeler C; Takvorian T; Elias A; Antin J H; Greenough T; Eder J P
Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1699-706.
1990: Antin J H; Weinberg D S; Rosenthal D S
Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia.
Experimental hematology 1990;18(4):266-70.
1990: Wheeler C; Antin J H; Churchill W H; Come S E; Smith B R; Bubley G J; Rosenthal D S; Rappaport J M; Ault K A; Schnipper L E
Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):648-56.
1990: Byers V S; Henslee P J; Kernan N A; Blazar B R; Gingrich R; Phillips G L; LeMaistre C F; Gilliland G; Antin J H; Martin P
Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.
Blood 1990;75(7):1426-32.
1990: Roth M S; Antin J H; Bingham E L; Ginsburg D
Use of polymerase chain reaction-detected sequence polymorphisms to document engraftment following allogeneic bone marrow transplantation.
Transplantation 1990;49(4):714-20.
1990: Antin J H; Bierer B E; Smith B R; Guinan E C; Provost M M; Ferrara J; Macklis R M; Tarbell N J; Blythman H; Bouloux C
Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
Progress in clinical and biological research 1990;333():207-15.
1989: Mitus A J; Stein R; Rappeport J M; Antin J H; Weinstein H J; Alper C A; Smith B R
Monoclonal and oligoclonal gammopathy after bone marrow transplantation.
Blood 1989;74(8):2764-8.
1989: Roth M S; Antin J H; Bingham E L; Ginsburg D
Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.
Blood 1989;74(2):882-5.
1989: Ibrahim R E; Teich D; Smith B R; Antin J; Olivier A P; Weinberg D S
Flow cytometric surface light chain analysis of lymphocyte-rich effusions. A useful adjunct to cytologic diagnosis.
Cancer 1989;63(10):2024-9.
1989: Emerson S G; Antin J H
Bone marrow progenitor cells induce a regulatory autologous proliferative T lymphocyte response.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(3):766-72.
1988: Bierer B E; Emerson S G; Antin J; Maziarz R; Rappeport J M; Smith B R; Burakoff S J
Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation.
Transplantation 1988;46(6):835-9.
1988: Maziarz R T; Tepler I; Antin J H; Keroack M A; Churchill W H; Holmes W; Rappeport J
Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemia.
Annals of internal medicine 1988;109(4):292-4.
1988: Antin J H; Smith B R; Holmes W; David R N; Rosenthal S
Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
Behring Institute Mitteilungen 1988;(83):149-53.
1988: Antin J H; Smith B R; Holmes W; Rosenthal D S
Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
Blood 1988;72(2):705-13.
1988: Stone R M; Maguire M; Goldberg M A; Antin J H; Rosenthal D S; Mayer R J
Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Blood 1988;71(3):690-6.
1987: Antin J H; Ault K A; Rappeport J M; Smith B R
B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes.
The Journal of clinical investigation 1987;80(2):325-32.
1986: Goldberg M A; Antin J H; Guinan E C; Rappeport J M
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor.
Blood 1986;68(5):1114-8.
1985: Antin J H; Ginsburg D; Smith B R; Nathan D G; Orkin S H; Rappeport J M
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment.
Blood 1985;66(6):1247-50.
1985: Ginsburg D; Antin J H; Smith B R; Orkin S H; Rappeport J M
Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms.
The Journal of clinical investigation 1985;75(2):596-603.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Joseph Antin

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Living Beings

Phenomena

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Joseph Antin (preview)

All Publications